| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/10/2008 | WO2008080972A1 Substituted oxindole derivative and its use as a vasopressin receptor modulator |
| 07/10/2008 | WO2008080971A1 Substituted oxindole derivative and its use as a vasopressin receptor ligand |
| 07/10/2008 | WO2008080970A1 Substituted oxindole derivative and its use as a vasopressin receptor ligand |
| 07/10/2008 | WO2008080969A1 Carboxamide compounds and their use as calpain inhibitors |
| 07/10/2008 | WO2008080844A1 Azaspiro derivatives |
| 07/10/2008 | WO2008080842A1 Indoles |
| 07/10/2008 | WO2008080821A1 Crystalline forms glyt1 |
| 07/10/2008 | WO2008080333A1 Compound preparation for enhancing memory |
| 07/10/2008 | WO2008080290A1 Selective m4 receptor antagonist and its medical use |
| 07/10/2008 | WO2008080268A1 Derivates of substituted tartaric aicd and usage for preparating beta secretase inhibitors |
| 07/10/2008 | WO2008061795A3 N- (methyl) -1h- pyrazol- 3 -amine, n- (methyl) -pyridin-2-amine and n- (methyl) -thiaz0l-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins, like e.g. alzheimer's |
| 07/10/2008 | WO2008056266A3 Substituted 8-piperidinyl-2-pyridinyl-pyrimido [1,2-a]pyrimidin-6-one and 8-piperidinyl-2-pyrimidinyl-pyrimido[1,2-a]pyrimidin-6-one derivatives |
| 07/10/2008 | WO2008020744A3 Method for extracting the nerve tissue growth factor from v.lebetina linnaeus venom |
| 07/10/2008 | WO2008011348A3 Humanized antibody against amyloid beta |
| 07/10/2008 | WO2006052496A8 Compound useful for the treatment or prevention of cognitive disorders associated with diabetes and the use thereof |
| 07/10/2008 | WO2002072778A3 Method for identifying inhibitors of g protein coupled receptor signaling |
| 07/10/2008 | US20080168573 Transgenic worms for use as bioreactor for expression of carboxylesterase-1for use in treatment of alzheimer's disease |
| 07/10/2008 | US20080167366 Use of 2-oxo-1-pyrrolidine derivatives for the preparation of a drug |
| 07/10/2008 | US20080167363 Such as melatonin, GR-135,531, or ramelteon in combination with an antidepressant, an ACE inhibitor, or a 5HT1 agonist; nervous system disorders, neurodegenerative disorders, psychological disorders, transplants |
| 07/10/2008 | US20080167362 Time-release tablets or capsules also containing an opoid or analgesic; cyclooxygenase-2 inhibitors |
| 07/10/2008 | US20080167361 Piperazinyl-substituted quinolinone compounds ;to treat nervous system diseases, neurodegenerative diseases; gastrointestinal tract disorders; cognition enhancers; 3-[4-(3-Ethylsulfanyl-benzenesulfonyl)-2-methoxy-phenyl]-pyrrolidine and 5-(3-Ethylsulfanyl-benzenesulfonyl)-2-pyrrolidin-3-yl-phenol |
| 07/10/2008 | US20080167359 guanidines such as (1H-benzoimidazol-2-yl)(2,6-dichlorophenyl)methylamine, used as proton pump inhibitors for prevention or treatment of respiratory system, sleep, urogenital or nervous ststem disorders; as antihypotensive, neuroleptic, antidepressants, anxiolytic, antiischemic or antilipemic agents |
| 07/10/2008 | US20080167357 Azabicyclo (3.1.0) Hexane Derivatives Useful as Modulators of Dopamine D3 Receptors |
| 07/10/2008 | US20080167351 Compounds Which Potentiate Glutamate Receptor and Uses Thereof in Medicine |
| 07/10/2008 | US20080167345 Amide substituted indazoles as poly(ADP-ribose)polymerase(PARP) inhibitors |
| 07/10/2008 | US20080167344 Indoles |
| 07/10/2008 | US20080167343 Methods and compositions using cholinesterase inhibitors |
| 07/10/2008 | US20080167338 Compounds and methods for kinase modulation, and indications therefor |
| 07/10/2008 | US20080167337 Substituted 3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2h-pyrido[2,1-a]isoquinolin-2-ol compounds and methods relating thereto |
| 07/10/2008 | US20080167334 Modulators of estrogen receptor alpha/beta G protein-coupled receptor 30, e.g., 1-(4-(6-Bromo-benzo[1,3]dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl)1-ethanone; treating diseases such as cancer, neurodegenerative disorders, obesity, osteoporosis, and symptoms of menopause |
| 07/10/2008 | US20080167329 3,4-Dihydroquinazolin-2(1H)-ones, e.g., 4-Ethyl-6-chloro-4-phenyl-3-(2,2,2-trifluoroethyl)-3,4-dihydroquinazolin-2(1H)-one; treatment of epilepsy, pain, movement disorders, cognitive disorders, psychological disorders, sleep disorders, hot flashes, fibromyalgia, and drug withdrawl |
| 07/10/2008 | US20080167324 Thiazolymethyl and Oxazolylmethyl Heteroaryl Derivatives |
| 07/10/2008 | US20080167320 Compounds are selective ligands for the dopamine D3 receptor; psychotic or depressive disorders, dyskinesia, essential tremor; 2-{4-[4-(3-trifluoromethylphenyl)piperazin-1-yl]butyl}amino-4-phenylpyridine; neuropsychiatry; drug dependency/abuse |
| 07/10/2008 | US20080167319 7-(4-(4-[3-chloro-2-(trifluoromethyl)phenyl]piperazin-1-yl)butoxy)-[1,8]-naphthyridin-2(1h)-one |
| 07/10/2008 | US20080167318 Pharmaceutically active pyrrolidine derivatives |
| 07/10/2008 | US20080167314 Condensed Imidazole Compound And Use Thereof |
| 07/10/2008 | US20080167310 Syndrome X, antidiabetic agents; hypoglycemic agents;antilipemic agents; artherosclerosis; cardiovascular disorders |
| 07/10/2008 | US20080167303 Aryl sulfamide derivatives and methods of their use |
| 07/10/2008 | US20080167291 Neurogenesis by modulating angiotensin |
| 07/10/2008 | US20080167290 Particularly citalopram, escitalopram, fluoxetine, sertraline, paroxetine, fluvoxamine, venlafaxine, dapoxetine, nefazodone, imipramin, femoxetine or clomipramine; treatment of depression and other affective disorders |
| 07/10/2008 | US20080167289 Pyrimidinohydrodiazepinones, e.g., 2-(1,6-dihydro-4-methyl-6-oxopyridin-3-ylamino)-9-cyclopentyl-8,9-dihydro-5,7,7-trimethyl-5H-pyrimido[4,5-b][1,4]diazepin-6(7H)-one; especially c-Met kinase inhibitors; anticancer agents |
| 07/10/2008 | US20080167286 Pharmaceutical compositions and their methods of use |
| 07/10/2008 | US20080167257 Therapy of acroparaesthsia, allergic (psoric) conditions, allergic reactions, alopecia, amnesia, anaphrodisia, angina, arthritis, asthenopia, biliary sycosis, burns, cancerous conditions, such as colon cancer, malignant melanoma and malignant nasal polyps, carpal tunnel syndrome, colds, conjunctivitis |
| 07/10/2008 | US20080167249 Protective factors against inflammation, burns and noxious stimuli |
| 07/10/2008 | US20080167248 Anti-Aging Effects Of Substance P |
| 07/10/2008 | US20080167247 modulator of PKC V5 isozyme-specific peptide, or a modification, derivation, fragment, combination, or hybrid thereof; treatment of pain, cancer |
| 07/10/2008 | US20080167224 polypeptide with at least one amino acid replacement at position at 132, 134, 170, or 181; agonist of MET receptor; induce DNA synthesis, protect from liver damage from acetaminophen; gene therapy; promote cell growth angiogenesis, treatment of cardiovascular, hepatic, musculoskeletal, neuronal diseases |
| 07/10/2008 | US20080167216 for treating Parkinson's disease in a mammal, comprising:providing a quantity of a viral vector expressing an N-terminal of sonic hedgehog ("ShhN"); andadministering a therapeutically effective amount of the quantity of viral vector to the mammal. |
| 07/10/2008 | US20080166800 Method and medicament for inhibiting the expression of a given gene |
| 07/10/2008 | US20080166768 Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof |
| 07/10/2008 | US20080166743 Trp8, a transient receptor potential channel expressed in taste receptor cells |
| 07/10/2008 | US20080166413 Topical pharmaceutical formulations and methods of treatment |
| 07/10/2008 | US20080166408 Oral Dosage Form Comprising Rosiglitazone |
| 07/10/2008 | US20080166404 Bioadhesive drug formulations for oral transmucosal delivery |
| 07/10/2008 | US20080166395 Pouches for nicotine replacement therapy; coconuts, flavors, herbs |
| 07/10/2008 | US20080166374 Formulating an anti-cancer vaccine comprising an agent that can stimulate an immune response against IL-13R alpha 2 outside of the subject, and administering the vaccine to the subject |
| 07/10/2008 | US20080166362 New effector conjugates, process for their production and their pharmaceutical use |
| 07/10/2008 | US20080166353 Using immunoglobulin specific to receptor for OX-2 membrane glycoprotein as diagnostic and therapeutic tool for treatment and prevention of asthma, infection, allergies, skin and cell proliferative disorders |
| 07/10/2008 | US20080166332 Methods of Treatment of Amyloidosis Using Subsituted Ethanolcyclicamine Aspartyl Protease Inhibitors |
| 07/10/2008 | US20080166318 Methods and therapeutic combinations for the treatment of demyelination |
| 07/10/2008 | US20080166299 Prevent accumulation of amyloid deposits |
| 07/10/2008 | DE202008005904U1 Kalt geknackte Cashewnuss zur Anwendung in der Therapie Cold cracked cashew nut for use in the therapy |
| 07/10/2008 | DE102007001370A1 RNA-kodierte Antikörper RNA-encoded antibody |
| 07/10/2008 | CA2674186A1 Use of somatostatin analogs in cluster headache |
| 07/10/2008 | CA2674154A1 Azaspiro derivatives |
| 07/10/2008 | CA2674141A1 Spiropiperidine derivatives as nk3 antagonists |
| 07/10/2008 | CA2674140A1 Method of providing disease-specific binding molecules and targets |
| 07/10/2008 | CA2674133A1 Indoles |
| 07/10/2008 | CA2673667A1 Crystalline forms glyt1 |
| 07/10/2008 | CA2673584A1 Substituted oxindole derivatives and their use as vasopressin receptor ligands |
| 07/10/2008 | CA2673580A1 Carboxamide compounds and their use as calpain inhibitors |
| 07/10/2008 | CA2672534A1 Analgesic agent comprising cyclic phosphatidic acid derivative |
| 07/10/2008 | CA2669821A1 2-aza-bicyclo[3.1.0]hexane derivatives |
| 07/09/2008 | EP1942187A1 Cytokine protein family |
| 07/09/2008 | EP1942113A1 Neuronal differentiation inhibitor peptide and use thereof |
| 07/09/2008 | EP1942105A1 Aminodihydrothiazine derivative |
| 07/09/2008 | EP1942101A1 Secretase inhibitor |
| 07/09/2008 | EP1942100A1 Amorphous and crystalline forms of rivastigmine hydrogentartrate |
| 07/09/2008 | EP1941902A1 Use of Somatostatin analogs in cluster headache |
| 07/09/2008 | EP1941898A2 Treatment of neuromuscular disorders and conditions with different botulinum serotype |
| 07/09/2008 | EP1941890A1 Hematopoietic stem cell proliferator |
| 07/09/2008 | EP1941878A1 Sedative non-benzodiazepine formulations |
| 07/09/2008 | EP1941872A1 Use of TNF-alpha inhibitors for treating nerve root injury |
| 07/09/2008 | EP1941870A2 Perfume Composition comprising perilla aldehyde |
| 07/09/2008 | EP1940873A2 Novel fgf receptor binding compounds comprising peptide fragments of neural cell adhesion molecule l1 |
| 07/09/2008 | EP1940870A2 Conserved membrane activator of calcineurin (cmac), a novel therapeutic protein and target |
| 07/09/2008 | EP1940833A1 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof |
| 07/09/2008 | EP1940832A1 Novel 1-aza bicycloalkyl derivatives for the treatment of psychotic and neurodegenerative disorders |
| 07/09/2008 | EP1940831A1 Salicylate and gentisate salts of a piperazine compound |
| 07/09/2008 | EP1940830A1 Glucuronate salt of a piperazine compound |
| 07/09/2008 | EP1940829A2 Imidazole derivatives and their use for modulating the gabaa receptor complex |
| 07/09/2008 | EP1940828A2 Heterocyclic aspartyl protease inhibitors |
| 07/09/2008 | EP1940824A1 Selected cgrp antagonists method for production and use thereof as medicament |
| 07/09/2008 | EP1940822A1 Imidazole derivatives and their use for modulating the gaba-a receptor complex |
| 07/09/2008 | EP1940819A1 Phosphodiesterase 10 inhibitors |
| 07/09/2008 | EP1940818A1 Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase n inhibitors |
| 07/09/2008 | EP1940817A1 Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment |
| 07/09/2008 | EP1940804A2 Novel pyrimidine-2,4-diamine derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
| 07/09/2008 | EP1940803A1 1,2-diarylimidazoles for use as cbi modulators |
| 07/09/2008 | EP1940795A1 N-oxo-heterocycle and n-oxo-alkyl quinoline-4-carboxamides as nk-3 receptor ligands |